<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1D484F6-1D6B-4A26-8B4B-CEF4502C9AD9"><gtr:id>D1D484F6-1D6B-4A26-8B4B-CEF4502C9AD9</gtr:id><gtr:name>NeuroNova AB</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E4599F86-E5D9-40AD-A427-4782E12EA8BF"><gtr:id>E4599F86-E5D9-40AD-A427-4782E12EA8BF</gtr:id><gtr:name>Swiss Federal Institute of Technology in Lausanne (EPFL)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FC68D4D9-FDF1-4BA8-826F-1AF5D36C82CE"><gtr:id>FC68D4D9-FDF1-4BA8-826F-1AF5D36C82CE</gtr:id><gtr:name>Centre for Genomic Regulation (CRG)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F7233F24-93D3-40B6-A4C4-54222647E41F"><gtr:id>F7233F24-93D3-40B6-A4C4-54222647E41F</gtr:id><gtr:name>University of Bonn</gtr:name><gtr:address><gtr:line1>Katzenburgweg 5</gtr:line1><gtr:line4>Bonn</gtr:line4><gtr:line5>D-53115</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D256583-980C-4154-8084-3B1D98B6FB27"><gtr:id>4D256583-980C-4154-8084-3B1D98B6FB27</gtr:id><gtr:name>Stem Cell Technologies</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2E03CB24-1D08-4A8B-8E29-C52EEAEC5EF9"><gtr:id>2E03CB24-1D08-4A8B-8E29-C52EEAEC5EF9</gtr:id><gtr:name>Institute of Biomedical Imagery (I2BM)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1DBA2DB-52A7-429E-A5A3-A2AF99FB8847"><gtr:id>A1DBA2DB-52A7-429E-A5A3-A2AF99FB8847</gtr:id><gtr:name>European Research Centre for Biology and Medicine (Centre Europ?en de Recherche en Biologie et en M?decine)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0F2B82FC-DE60-46A1-B1FB-3C4EF6402A64"><gtr:id>0F2B82FC-DE60-46A1-B1FB-3C4EF6402A64</gtr:id><gtr:name>JDRF Center for Beta Cell Therapy in Diabetes</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6CF044E5-A141-445C-853D-84266979F62E"><gtr:id>6CF044E5-A141-445C-853D-84266979F62E</gtr:id><gtr:name>NsGene A/S</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/473F7B5C-70FE-4079-A7A4-9B33054D3495"><gtr:id>473F7B5C-70FE-4079-A7A4-9B33054D3495</gtr:id><gtr:name>University of Rome I (La Sapienza)</gtr:name><gtr:address><gtr:line1>University of Rome</gtr:line1><gtr:line2>Via Pietro Roselli</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FC20619C-24CC-4562-8F2A-B1C34FB19874"><gtr:id>FC20619C-24CC-4562-8F2A-B1C34FB19874</gtr:id><gtr:name>University Medical Centre Nijmegen</gtr:name><gtr:address><gtr:line1>Uinversity Medical Centre Nijmegen</gtr:line1><gtr:line2>PO Box 9101</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/75E77BF3-29B4-4699-9CD9-223230E8A463"><gtr:id>75E77BF3-29B4-4699-9CD9-223230E8A463</gtr:id><gtr:name>Babraham Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/85361DD1-CBC3-4B57-B16F-1D408D564D50"><gtr:id>85361DD1-CBC3-4B57-B16F-1D408D564D50</gtr:id><gtr:name>Sapio</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/43ECF77B-CD97-49C9-812D-40CB69D1D03B"><gtr:id>43ECF77B-CD97-49C9-812D-40CB69D1D03B</gtr:id><gtr:name>San Raffaele Hospital</gtr:name><gtr:address><gtr:line1>29 Via Prinetti</gtr:line1><gtr:region>outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/19A2A787-2FDB-4397-9885-403B7C582232"><gtr:id>19A2A787-2FDB-4397-9885-403B7C582232</gtr:id><gtr:name>Leiden University Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8B42480C-C16B-45BD-A61E-FCB97FD77B2C"><gtr:id>8B42480C-C16B-45BD-A61E-FCB97FD77B2C</gtr:id><gtr:name>RIKEN</gtr:name><gtr:address><gtr:line1>1-7-22, Suehiro-cho</gtr:line1><gtr:line2>Tsurumi-ku</gtr:line2><gtr:line4>Yokohama</gtr:line4><gtr:line5>Kanagawa 230-0045</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/91DA30EC-86C6-41D7-B9B5-5F79F1F73FA7"><gtr:id>91DA30EC-86C6-41D7-B9B5-5F79F1F73FA7</gtr:id><gtr:name>European Molecular Biology Laboratory</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8D343C8-E5A9-4C4D-8EAB-E22A3372B0B3"><gtr:id>A8D343C8-E5A9-4C4D-8EAB-E22A3372B0B3</gtr:id><gtr:name>Life and Brain GmbH</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/33735849-D455-4914-AB52-D4E0A8F67091"><gtr:id>33735849-D455-4914-AB52-D4E0A8F67091</gtr:id><gtr:name>Pluriomics BV</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B80F4B80-4E79-45BF-9927-E2906FDA3D3F"><gtr:id>B80F4B80-4E79-45BF-9927-E2906FDA3D3F</gtr:id><gtr:name>Dando, Weiss &amp; Colucci Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED"><gtr:id>6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED</gtr:id><gtr:name>Technical University Dresden</gtr:name><gtr:address><gtr:line1>TU Dresden</gtr:line1><gtr:postCode>D-01062</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9EED95BB-25DC-4032-8E45-C3EA7277E78A"><gtr:id>9EED95BB-25DC-4032-8E45-C3EA7277E78A</gtr:id><gtr:name>University of Milan</gtr:name><gtr:address><gtr:line1>Via Festa del Perdono 7</gtr:line1><gtr:postCode>20122</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/38604300-D348-417A-994D-AC90FDF777D7"><gtr:id>38604300-D348-417A-994D-AC90FDF777D7</gtr:id><gtr:name>National University of Ireland Galway</gtr:name><gtr:address><gtr:line1>National University of Ireland Galway</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Ireland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9A22541F-DA58-481E-8D0C-C4BCF4EA030E"><gtr:id>9A22541F-DA58-481E-8D0C-C4BCF4EA030E</gtr:id><gtr:name>EMBL - European Bioinformatics Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB10 1SD</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Biochemistry</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1D484F6-1D6B-4A26-8B4B-CEF4502C9AD9"><gtr:id>D1D484F6-1D6B-4A26-8B4B-CEF4502C9AD9</gtr:id><gtr:name>NeuroNova AB</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E4599F86-E5D9-40AD-A427-4782E12EA8BF"><gtr:id>E4599F86-E5D9-40AD-A427-4782E12EA8BF</gtr:id><gtr:name>Swiss Federal Institute of Technology in Lausanne (EPFL)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FC68D4D9-FDF1-4BA8-826F-1AF5D36C82CE"><gtr:id>FC68D4D9-FDF1-4BA8-826F-1AF5D36C82CE</gtr:id><gtr:name>Centre for Genomic Regulation (CRG)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7233F24-93D3-40B6-A4C4-54222647E41F"><gtr:id>F7233F24-93D3-40B6-A4C4-54222647E41F</gtr:id><gtr:name>University of Bonn</gtr:name><gtr:address><gtr:line1>Katzenburgweg 5</gtr:line1><gtr:line4>Bonn</gtr:line4><gtr:line5>D-53115</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D256583-980C-4154-8084-3B1D98B6FB27"><gtr:id>4D256583-980C-4154-8084-3B1D98B6FB27</gtr:id><gtr:name>Stem Cell Technologies</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2E03CB24-1D08-4A8B-8E29-C52EEAEC5EF9"><gtr:id>2E03CB24-1D08-4A8B-8E29-C52EEAEC5EF9</gtr:id><gtr:name>Institute of Biomedical Imagery (I2BM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1DBA2DB-52A7-429E-A5A3-A2AF99FB8847"><gtr:id>A1DBA2DB-52A7-429E-A5A3-A2AF99FB8847</gtr:id><gtr:name>European Research Centre for Biology and Medicine (Centre Europ?en de Recherche en Biologie et en M?decine)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0F2B82FC-DE60-46A1-B1FB-3C4EF6402A64"><gtr:id>0F2B82FC-DE60-46A1-B1FB-3C4EF6402A64</gtr:id><gtr:name>JDRF Center for Beta Cell Therapy in Diabetes</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6CF044E5-A141-445C-853D-84266979F62E"><gtr:id>6CF044E5-A141-445C-853D-84266979F62E</gtr:id><gtr:name>NsGene A/S</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/473F7B5C-70FE-4079-A7A4-9B33054D3495"><gtr:id>473F7B5C-70FE-4079-A7A4-9B33054D3495</gtr:id><gtr:name>University of Rome I (La Sapienza)</gtr:name><gtr:address><gtr:line1>University of Rome</gtr:line1><gtr:line2>Via Pietro Roselli</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FC20619C-24CC-4562-8F2A-B1C34FB19874"><gtr:id>FC20619C-24CC-4562-8F2A-B1C34FB19874</gtr:id><gtr:name>University Medical Centre Nijmegen</gtr:name><gtr:address><gtr:line1>Uinversity Medical Centre Nijmegen</gtr:line1><gtr:line2>PO Box 9101</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/75E77BF3-29B4-4699-9CD9-223230E8A463"><gtr:id>75E77BF3-29B4-4699-9CD9-223230E8A463</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/85361DD1-CBC3-4B57-B16F-1D408D564D50"><gtr:id>85361DD1-CBC3-4B57-B16F-1D408D564D50</gtr:id><gtr:name>Sapio</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/43ECF77B-CD97-49C9-812D-40CB69D1D03B"><gtr:id>43ECF77B-CD97-49C9-812D-40CB69D1D03B</gtr:id><gtr:name>San Raffaele Hospital</gtr:name><gtr:address><gtr:line1>29 Via Prinetti</gtr:line1><gtr:region>outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/19A2A787-2FDB-4397-9885-403B7C582232"><gtr:id>19A2A787-2FDB-4397-9885-403B7C582232</gtr:id><gtr:name>Leiden University Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8B42480C-C16B-45BD-A61E-FCB97FD77B2C"><gtr:id>8B42480C-C16B-45BD-A61E-FCB97FD77B2C</gtr:id><gtr:name>RIKEN</gtr:name><gtr:address><gtr:line1>1-7-22, Suehiro-cho</gtr:line1><gtr:line2>Tsurumi-ku</gtr:line2><gtr:line4>Yokohama</gtr:line4><gtr:line5>Kanagawa 230-0045</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/91DA30EC-86C6-41D7-B9B5-5F79F1F73FA7"><gtr:id>91DA30EC-86C6-41D7-B9B5-5F79F1F73FA7</gtr:id><gtr:name>European Molecular Biology Laboratory</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8D343C8-E5A9-4C4D-8EAB-E22A3372B0B3"><gtr:id>A8D343C8-E5A9-4C4D-8EAB-E22A3372B0B3</gtr:id><gtr:name>Life and Brain GmbH</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/33735849-D455-4914-AB52-D4E0A8F67091"><gtr:id>33735849-D455-4914-AB52-D4E0A8F67091</gtr:id><gtr:name>Pluriomics BV</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B80F4B80-4E79-45BF-9927-E2906FDA3D3F"><gtr:id>B80F4B80-4E79-45BF-9927-E2906FDA3D3F</gtr:id><gtr:name>Dando, Weiss &amp; Colucci Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED"><gtr:id>6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED</gtr:id><gtr:name>Technical University Dresden</gtr:name><gtr:address><gtr:line1>TU Dresden</gtr:line1><gtr:postCode>D-01062</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9EED95BB-25DC-4032-8E45-C3EA7277E78A"><gtr:id>9EED95BB-25DC-4032-8E45-C3EA7277E78A</gtr:id><gtr:name>University of Milan</gtr:name><gtr:address><gtr:line1>Via Festa del Perdono 7</gtr:line1><gtr:postCode>20122</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/38604300-D348-417A-994D-AC90FDF777D7"><gtr:id>38604300-D348-417A-994D-AC90FDF777D7</gtr:id><gtr:name>National University of Ireland Galway</gtr:name><gtr:address><gtr:line1>National University of Ireland Galway</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Ireland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9A22541F-DA58-481E-8D0C-C4BCF4EA030E"><gtr:id>9A22541F-DA58-481E-8D0C-C4BCF4EA030E</gtr:id><gtr:name>EMBL - European Bioinformatics Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB10 1SD</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EF487274-CC13-4315-8734-14C1977A4AD2"><gtr:id>EF487274-CC13-4315-8734-14C1977A4AD2</gtr:id><gtr:firstName>Austin</gtr:firstName><gtr:surname>Smith</gtr:surname><gtr:orcidId>0000-0002-3029-4682</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5A422CFD-58E7-4BD4-B2CE-39808D50D2BB"><gtr:id>5A422CFD-58E7-4BD4-B2CE-39808D50D2BB</gtr:id><gtr:firstName>Jennifer</gtr:firstName><gtr:surname>Nichols</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1001028"><gtr:id>6DF96CDF-B5F6-4439-8959-703F56659860</gtr:id><gtr:title>CAPTURE OF HUMAN GROUND STATE PLURIPOTENT STEM CELLS</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1001028</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2016-10-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2424521</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>Austin Smith provided the voice over for the Stem Cell Revolutions film. Featuring beautiful hand-drawn animations and interviews with leading stem cell scientists, Stem Cell Revolutions charts the history and scientific evolution of stem cell research - from the earliest experiments that first revealed stem cells in the body, to leading current scientific and clinical developments</gtr:description><gtr:id>D02188FD-3B64-41F4-ACFF-61DDDFA0B9E0</gtr:id><gtr:impact>Increased understanding of Stem Cell Biology on an international scale</gtr:impact><gtr:outcomeId>54627dc7454846.70355873</gtr:outcomeId><gtr:title>Stem Cell Revolutions</gtr:title><gtr:type>Film/Video/Animation</gtr:type><gtr:url>http://www.stemcellrevolutions.com/watch</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health and Medical Research (INSERM)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>EuroStemCell</gtr:description><gtr:id>3FDB2107-923B-4B97-88DA-2DE997E5B720</gtr:id><gtr:impact>www.eurostemcell.org</gtr:impact><gtr:outcomeId>D4A636509B7-10</gtr:outcomeId><gtr:partnerContribution>EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh</gtr:partnerContribution><gtr:piContribution>Austin is a principal investigator for this collaboration</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>RIKEN</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:department>RIKEN Center for Developmental Biology</gtr:department><gtr:description>JPA/ CSCR</gtr:description><gtr:id>B70809E9-817E-4B50-808F-E473FD605F85</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>faR5bAgX3Fs-1</gtr:outcomeId><gtr:partnerContribution>Metanalysis of transcriptional circuitries and simulation of robustness, flexibility and dynamic heterogeneity</gtr:partnerContribution><gtr:piContribution>Metanalysis of transcriptional circuitries and simulation of robustness, flexibility and dynamic heterogeneity</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>EMBL European Bioinformatics Institute (EMBL - EBI)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>EBI / SCI</gtr:description><gtr:id>90AAAC46-0CAD-42ED-B299-3F6909C0F4DE</gtr:id><gtr:impact>Publication: Identification of the missing pluripotency mediator downstream of leukaemia inhibitory</gtr:impact><gtr:outcomeId>qmouzBwm3fC-1</gtr:outcomeId><gtr:partnerContribution>Deep sequence analysis</gtr:partnerContribution><gtr:piContribution>Deep sequence analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Research Centre for Biology and Medicine (Centre Europ?en de Recherche en Biologie et en M?decine)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>FP7 Project Pluripotent Stem Cell resources for mesodermal medicine (PluriMes)</gtr:description><gtr:id>5F3917DE-0854-49A4-BCB8-02792F9D096F</gtr:id><gtr:impact>DOI: http://dx.doi.org/10.1016/j.cell.2014.08.029

DOI:10.1038/nprot.2014.102</gtr:impact><gtr:outcomeId>5462001a6ca3e9.89776785-9</gtr:outcomeId><gtr:partnerContribution>By interlinking complementary biological and computational expertise, the partners aim to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells. By harnessing the capacity of pluripotent stem cells to produce functional cell types with precision and at scale, researchers hope to enable new treatment modalities for degenerative diseases. The PluriMes project is specifically targeted at therapies for muscle, bone and cartilage.</gtr:partnerContribution><gtr:piContribution>Austin Smith is responsible for overall scientific coordination of the project and leads work package 1, translating current advances and understanding of rodent pluripotency to develop and refine conditions that promote homogeneous na&amp;iuml;ve state for human pluripotent stem cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>EUROSTEMCELL</gtr:description><gtr:id>F3DD45E1-D7FE-4C84-BA15-122CF5495005</gtr:id><gtr:impact>Not given</gtr:impact><gtr:outcomeId>D69578A10AB-9</gtr:outcomeId><gtr:partnerContribution>xxx</gtr:partnerContribution><gtr:piContribution>Austin Smith was the coordinator of this collaboration.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sapienza University of Rome</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>FP7 Project Pluripotent Stem Cell resources for mesodermal medicine (PluriMes)</gtr:description><gtr:id>6B7ED030-89B5-4D0A-BB35-CF3332663A05</gtr:id><gtr:impact>DOI: http://dx.doi.org/10.1016/j.cell.2014.08.029

DOI:10.1038/nprot.2014.102</gtr:impact><gtr:outcomeId>5462001a6ca3e9.89776785-2</gtr:outcomeId><gtr:partnerContribution>By interlinking complementary biological and computational expertise, the partners aim to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells. By harnessing the capacity of pluripotent stem cells to produce functional cell types with precision and at scale, researchers hope to enable new treatment modalities for degenerative diseases. The PluriMes project is specifically targeted at therapies for muscle, bone and cartilage.</gtr:partnerContribution><gtr:piContribution>Austin Smith is responsible for overall scientific coordination of the project and leads work package 1, translating current advances and understanding of rodent pluripotency to develop and refine conditions that promote homogeneous na&amp;iuml;ve state for human pluripotent stem cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>EuroStemCell</gtr:description><gtr:id>D821CF8B-4503-4A23-AC96-DEA1B550C9F5</gtr:id><gtr:impact>www.eurostemcell.org</gtr:impact><gtr:outcomeId>D4A636509B7-1</gtr:outcomeId><gtr:partnerContribution>EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh</gtr:partnerContribution><gtr:piContribution>Austin is a principal investigator for this collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NeuroNova AB</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>EUROSTEMCELL</gtr:description><gtr:id>6A799718-A0C0-4D9E-B886-7EF807DCD906</gtr:id><gtr:impact>Not given</gtr:impact><gtr:outcomeId>D69578A10AB-14</gtr:outcomeId><gtr:partnerContribution>xxx</gtr:partnerContribution><gtr:piContribution>Austin Smith was the coordinator of this collaboration.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>JDRF Center for Beta Cell Therapy in Diabetes</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>EuroStemCell</gtr:description><gtr:id>40DF2AA4-F785-4F38-90F9-499B08E8A2E7</gtr:id><gtr:impact>www.eurostemcell.org</gtr:impact><gtr:outcomeId>D4A636509B7-3</gtr:outcomeId><gtr:partnerContribution>EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh</gtr:partnerContribution><gtr:piContribution>Austin is a principal investigator for this collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leiden University Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>FP7 Project Pluripotent Stem Cell resources for mesodermal medicine (PluriMes)</gtr:description><gtr:id>4E3C45CD-BB38-4D08-BF7A-F3B01F31AD93</gtr:id><gtr:impact>DOI: http://dx.doi.org/10.1016/j.cell.2014.08.029

DOI:10.1038/nprot.2014.102</gtr:impact><gtr:outcomeId>5462001a6ca3e9.89776785-7</gtr:outcomeId><gtr:partnerContribution>By interlinking complementary biological and computational expertise, the partners aim to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells. By harnessing the capacity of pluripotent stem cells to produce functional cell types with precision and at scale, researchers hope to enable new treatment modalities for degenerative diseases. The PluriMes project is specifically targeted at therapies for muscle, bone and cartilage.</gtr:partnerContribution><gtr:piContribution>Austin Smith is responsible for overall scientific coordination of the project and leads work package 1, translating current advances and understanding of rodent pluripotency to develop and refine conditions that promote homogeneous na&amp;iuml;ve state for human pluripotent stem cells.</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>NeuroStemCell</gtr:description><gtr:id>441BE356-9FCE-40CC-B23C-46425D195D61</gtr:id><gtr:impact>http://www.neurostemcell.org/</gtr:impact><gtr:outcomeId>701A2E19E3D-4</gtr:outcomeId><gtr:partnerContribution>European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson&amp;acute;s disease and Huntington&amp;acute;s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.</gtr:partnerContribution><gtr:piContribution>Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Milan</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>EuroStemCell</gtr:description><gtr:id>2082CF56-FAA1-413F-8460-62C7F53620FE</gtr:id><gtr:impact>www.eurostemcell.org</gtr:impact><gtr:outcomeId>D4A636509B7-2</gtr:outcomeId><gtr:partnerContribution>EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh</gtr:partnerContribution><gtr:piContribution>Austin is a principal investigator for this collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Babraham Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Stem Cell Sciences UK Ltd</gtr:department><gtr:description>EUROSTEMCELL</gtr:description><gtr:id>209E76C5-956A-41B6-B2F5-486172F69E37</gtr:id><gtr:impact>Not given</gtr:impact><gtr:outcomeId>D69578A10AB-12</gtr:outcomeId><gtr:partnerContribution>xxx</gtr:partnerContribution><gtr:piContribution>Austin Smith was the coordinator of this collaboration.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>EUROSTEMCELL</gtr:description><gtr:id>A4990930-E049-4908-828C-97B86B3B5C53</gtr:id><gtr:impact>Not given</gtr:impact><gtr:outcomeId>D69578A10AB-1</gtr:outcomeId><gtr:partnerContribution>xxx</gtr:partnerContribution><gtr:piContribution>Austin Smith was the coordinator of this collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lund University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>EuroStemCell</gtr:description><gtr:id>E86D883E-FF18-4235-A06A-175BFF5E3DD8</gtr:id><gtr:impact>www.eurostemcell.org</gtr:impact><gtr:outcomeId>D4A636509B7-7</gtr:outcomeId><gtr:partnerContribution>EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh</gtr:partnerContribution><gtr:piContribution>Austin is a principal investigator for this collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biosciences</gtr:department><gtr:description>NeuroStemCell</gtr:description><gtr:id>68459832-8E8F-4777-858F-6CE6CFEDF1E5</gtr:id><gtr:impact>http://www.neurostemcell.org/</gtr:impact><gtr:outcomeId>701A2E19E3D-5</gtr:outcomeId><gtr:partnerContribution>European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson&amp;acute;s disease and Huntington&amp;acute;s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.</gtr:partnerContribution><gtr:piContribution>Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centre for Genomic Regulation (CRG)</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>EuroStemCell</gtr:description><gtr:id>E6A8D14B-C6A2-4B14-89D1-E9F8CFA729FC</gtr:id><gtr:impact>www.eurostemcell.org</gtr:impact><gtr:outcomeId>D4A636509B7-6</gtr:outcomeId><gtr:partnerContribution>EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh</gtr:partnerContribution><gtr:piContribution>Austin is a principal investigator for this collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bonn</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Medical Centre Bonn</gtr:department><gtr:description>EUROSTEMCELL</gtr:description><gtr:id>A038A6D4-5741-4E63-9ED1-3380525DF5D0</gtr:id><gtr:impact>Not given</gtr:impact><gtr:outcomeId>D69578A10AB-8</gtr:outcomeId><gtr:partnerContribution>xxx</gtr:partnerContribution><gtr:piContribution>Austin Smith was the coordinator of this collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>EUROSTEMCELL</gtr:description><gtr:id>C5B6BE52-4FD7-45FF-8843-5EA7F869A7E2</gtr:id><gtr:impact>Not given</gtr:impact><gtr:outcomeId>D69578A10AB-16</gtr:outcomeId><gtr:partnerContribution>xxx</gtr:partnerContribution><gtr:piContribution>Austin Smith was the coordinator of this collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Swiss Federal Institute of Technology in Lausanne (EPFL)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>FP7 Project Pluripotent Stem Cell resources for mesodermal medicine (PluriMes)</gtr:description><gtr:id>3410101F-F81F-42BE-A574-B6D2D485AD4D</gtr:id><gtr:impact>DOI: http://dx.doi.org/10.1016/j.cell.2014.08.029

DOI:10.1038/nprot.2014.102</gtr:impact><gtr:outcomeId>5462001a6ca3e9.89776785-8</gtr:outcomeId><gtr:partnerContribution>By interlinking complementary biological and computational expertise, the partners aim to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells. By harnessing the capacity of pluripotent stem cells to produce functional cell types with precision and at scale, researchers hope to enable new treatment modalities for degenerative diseases. The PluriMes project is specifically targeted at therapies for muscle, bone and cartilage.</gtr:partnerContribution><gtr:piContribution>Austin Smith is responsible for overall scientific coordination of the project and leads work package 1, translating current advances and understanding of rodent pluripotency to develop and refine conditions that promote homogeneous na&amp;iuml;ve state for human pluripotent stem cells.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National University of Ireland, Galway (NUI)</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>EuroStemCell</gtr:description><gtr:id>49393D4D-9AA8-4D64-98BF-CB3680EE2975</gtr:id><gtr:impact>www.eurostemcell.org</gtr:impact><gtr:outcomeId>D4A636509B7-8</gtr:outcomeId><gtr:partnerContribution>EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh</gtr:partnerContribution><gtr:piContribution>Austin is a principal investigator for this collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>NeuroStemCell</gtr:description><gtr:id>F2FDB3E4-9EC0-4BC1-B520-DF006082F62B</gtr:id><gtr:impact>http://www.neurostemcell.org/</gtr:impact><gtr:outcomeId>701A2E19E3D-7</gtr:outcomeId><gtr:partnerContribution>European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson&amp;acute;s disease and Huntington&amp;acute;s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.</gtr:partnerContribution><gtr:piContribution>Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>EUROSTEMCELL</gtr:description><gtr:id>8EE0CB90-B444-45C9-9C54-9682F51BC989</gtr:id><gtr:impact>Not given</gtr:impact><gtr:outcomeId>D69578A10AB-3</gtr:outcomeId><gtr:partnerContribution>xxx</gtr:partnerContribution><gtr:piContribution>Austin Smith was the coordinator of this collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Radboud University Nijmegen Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Deep Sequencing</gtr:description><gtr:id>93C16A1E-BED5-46F1-8993-8DC1D3C1CC3D</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>iX3qxvBuBuj-1</gtr:outcomeId><gtr:partnerContribution>Deep Sequencing</gtr:partnerContribution><gtr:piContribution>Deep Sequencing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Milan</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>NeuroStemCell</gtr:description><gtr:id>4E035F79-8843-4F76-9737-50F8C2937C6B</gtr:id><gtr:impact>http://www.neurostemcell.org/</gtr:impact><gtr:outcomeId>701A2E19E3D-2</gtr:outcomeId><gtr:partnerContribution>European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson&amp;acute;s disease and Huntington&amp;acute;s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.</gtr:partnerContribution><gtr:piContribution>Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>NeuroStemCell</gtr:description><gtr:id>1D5858EA-55B6-44F3-B148-98420F5706DE</gtr:id><gtr:impact>http://www.neurostemcell.org/</gtr:impact><gtr:outcomeId>701A2E19E3D-9</gtr:outcomeId><gtr:partnerContribution>European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson&amp;acute;s disease and Huntington&amp;acute;s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.</gtr:partnerContribution><gtr:piContribution>Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Technical University of Dresden</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>FP7 Project Pluripotent Stem Cell resources for mesodermal medicine (PluriMes)</gtr:description><gtr:id>2976E913-1EF6-406E-82B1-9F3EBE4222BF</gtr:id><gtr:impact>DOI: http://dx.doi.org/10.1016/j.cell.2014.08.029

DOI:10.1038/nprot.2014.102</gtr:impact><gtr:outcomeId>5462001a6ca3e9.89776785-5</gtr:outcomeId><gtr:partnerContribution>By interlinking complementary biological and computational expertise, the partners aim to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells. By harnessing the capacity of pluripotent stem cells to produce functional cell types with precision and at scale, researchers hope to enable new treatment modalities for degenerative diseases. The PluriMes project is specifically targeted at therapies for muscle, bone and cartilage.</gtr:partnerContribution><gtr:piContribution>Austin Smith is responsible for overall scientific coordination of the project and leads work package 1, translating current advances and understanding of rodent pluripotency to develop and refine conditions that promote homogeneous na&amp;iuml;ve state for human pluripotent stem cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>EuroStemCell</gtr:description><gtr:id>DA12545C-3E8B-418C-9CE9-7523A6082188</gtr:id><gtr:impact>www.eurostemcell.org</gtr:impact><gtr:outcomeId>D4A636509B7-4</gtr:outcomeId><gtr:partnerContribution>EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh</gtr:partnerContribution><gtr:piContribution>Austin is a principal investigator for this collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sapio</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>BioRep</gtr:department><gtr:description>NeuroStemCell</gtr:description><gtr:id>94A0F7EA-C1B1-4376-9C5A-5879B8B2E830</gtr:id><gtr:impact>http://www.neurostemcell.org/</gtr:impact><gtr:outcomeId>701A2E19E3D-10</gtr:outcomeId><gtr:partnerContribution>European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson&amp;acute;s disease and Huntington&amp;acute;s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.</gtr:partnerContribution><gtr:piContribution>Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Molecular Biology Laboratory</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>EUROSTEMCELL</gtr:description><gtr:id>E5FA4946-FF33-4516-B32B-385AEB9D895B</gtr:id><gtr:impact>Not given</gtr:impact><gtr:outcomeId>D69578A10AB-7</gtr:outcomeId><gtr:partnerContribution>xxx</gtr:partnerContribution><gtr:piContribution>Austin Smith was the coordinator of this collaboration.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>FP7 Project Pluripotent Stem Cell resources for mesodermal medicine (PluriMes)</gtr:description><gtr:id>EAC3A400-2B6E-4936-AA27-E19143FAD0DB</gtr:id><gtr:impact>DOI: http://dx.doi.org/10.1016/j.cell.2014.08.029

DOI:10.1038/nprot.2014.102</gtr:impact><gtr:outcomeId>5462001a6ca3e9.89776785-6</gtr:outcomeId><gtr:partnerContribution>By interlinking complementary biological and computational expertise, the partners aim to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells. By harnessing the capacity of pluripotent stem cells to produce functional cell types with precision and at scale, researchers hope to enable new treatment modalities for degenerative diseases. The PluriMes project is specifically targeted at therapies for muscle, bone and cartilage.</gtr:partnerContribution><gtr:piContribution>Austin Smith is responsible for overall scientific coordination of the project and leads work package 1, translating current advances and understanding of rodent pluripotency to develop and refine conditions that promote homogeneous na&amp;iuml;ve state for human pluripotent stem cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bonn</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>NeuroStemCell</gtr:description><gtr:id>37F1B228-AB9D-4062-895A-6769B271DE84</gtr:id><gtr:impact>http://www.neurostemcell.org/</gtr:impact><gtr:outcomeId>701A2E19E3D-3</gtr:outcomeId><gtr:partnerContribution>European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson&amp;acute;s disease and Huntington&amp;acute;s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.</gtr:partnerContribution><gtr:piContribution>Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lund University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>NeuroStemCell</gtr:description><gtr:id>1157CD0E-8B5B-45B8-BB3C-E65102AE8121</gtr:id><gtr:impact>http://www.neurostemcell.org/</gtr:impact><gtr:outcomeId>701A2E19E3D-1</gtr:outcomeId><gtr:partnerContribution>European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson&amp;acute;s disease and Huntington&amp;acute;s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.</gtr:partnerContribution><gtr:piContribution>Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>JDRF Center for Beta Cell Therapy in Diabetes</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>Beta Cell Therapy / SCI</gtr:description><gtr:id>F18E5AD7-1786-4F7B-8809-65A808BAEF24</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>ewCRLq5dbQ5-1</gtr:outcomeId><gtr:partnerContribution>Beta Cell Therapy in Diabetes - European Framework 7</gtr:partnerContribution><gtr:piContribution>Beta Cell Therapy in Diabetes - European Framework 7</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health and Medical Research (INSERM)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>NeuroStemCell</gtr:description><gtr:id>23A4E508-6A63-4378-ADD1-6DF79E169FD0</gtr:id><gtr:impact>http://www.neurostemcell.org/</gtr:impact><gtr:outcomeId>701A2E19E3D-8</gtr:outcomeId><gtr:partnerContribution>European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson&amp;acute;s disease and Huntington&amp;acute;s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.</gtr:partnerContribution><gtr:piContribution>Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NsGene A/S</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>NeuroStemCell</gtr:description><gtr:id>B00D7B88-1EAD-4570-8FE2-BAA91F32BC1D</gtr:id><gtr:impact>http://www.neurostemcell.org/</gtr:impact><gtr:outcomeId>701A2E19E3D-11</gtr:outcomeId><gtr:partnerContribution>European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson&amp;acute;s disease and Huntington&amp;acute;s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.</gtr:partnerContribution><gtr:piContribution>Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Milan</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>EUROSTEMCELL</gtr:description><gtr:id>B9452857-484F-4DC3-A490-5335297D5C55</gtr:id><gtr:impact>Not given</gtr:impact><gtr:outcomeId>D69578A10AB-6</gtr:outcomeId><gtr:partnerContribution>xxx</gtr:partnerContribution><gtr:piContribution>Austin Smith was the coordinator of this collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>EUROSTEMCELL</gtr:description><gtr:id>45304987-E8CA-4408-B0C2-7015FF2B82F8</gtr:id><gtr:impact>Not given</gtr:impact><gtr:outcomeId>D69578A10AB-10</gtr:outcomeId><gtr:partnerContribution>xxx</gtr:partnerContribution><gtr:piContribution>Austin Smith was the coordinator of this collaboration.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>San Raffaele Hospital</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Stem Cell Research Institute</gtr:department><gtr:description>EUROSTEMCELL</gtr:description><gtr:id>A5CF7EFE-D1AF-4D03-B107-1D4771A218A6</gtr:id><gtr:impact>Not given</gtr:impact><gtr:outcomeId>D69578A10AB-5</gtr:outcomeId><gtr:partnerContribution>xxx</gtr:partnerContribution><gtr:piContribution>Austin Smith was the coordinator of this collaboration.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Babraham Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Stem Cell Sciences UK Ltd</gtr:department><gtr:description>NeuroStemCell</gtr:description><gtr:id>4FC4C52A-8730-44F0-940F-3768967DEDB2</gtr:id><gtr:impact>http://www.neurostemcell.org/</gtr:impact><gtr:outcomeId>701A2E19E3D-12</gtr:outcomeId><gtr:partnerContribution>European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson&amp;acute;s disease and Huntington&amp;acute;s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.</gtr:partnerContribution><gtr:piContribution>Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute of Biomedical Imagery (I2BM)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>NeuroStemCell</gtr:description><gtr:id>98F43E33-D7FC-4092-AF9F-F28EE1C1A489</gtr:id><gtr:impact>http://www.neurostemcell.org/</gtr:impact><gtr:outcomeId>701A2E19E3D-6</gtr:outcomeId><gtr:partnerContribution>European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson&amp;acute;s disease and Huntington&amp;acute;s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.</gtr:partnerContribution><gtr:piContribution>Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pluriomics BV</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>FP7 Project Pluripotent Stem Cell resources for mesodermal medicine (PluriMes)</gtr:description><gtr:id>7487388A-7714-4CC7-9D68-6437DCEFECA9</gtr:id><gtr:impact>DOI: http://dx.doi.org/10.1016/j.cell.2014.08.029

DOI:10.1038/nprot.2014.102</gtr:impact><gtr:outcomeId>5462001a6ca3e9.89776785-3</gtr:outcomeId><gtr:partnerContribution>By interlinking complementary biological and computational expertise, the partners aim to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells. By harnessing the capacity of pluripotent stem cells to produce functional cell types with precision and at scale, researchers hope to enable new treatment modalities for degenerative diseases. The PluriMes project is specifically targeted at therapies for muscle, bone and cartilage.</gtr:partnerContribution><gtr:piContribution>Austin Smith is responsible for overall scientific coordination of the project and leads work package 1, translating current advances and understanding of rodent pluripotency to develop and refine conditions that promote homogeneous na&amp;iuml;ve state for human pluripotent stem cells.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Biosciences</gtr:department><gtr:description>FP7 Project Pluripotent Stem Cell resources for mesodermal medicine (PluriMes)</gtr:description><gtr:id>860E354E-CE67-42BF-BDAF-DD2D40DF9BF6</gtr:id><gtr:impact>DOI: http://dx.doi.org/10.1016/j.cell.2014.08.029

DOI:10.1038/nprot.2014.102</gtr:impact><gtr:outcomeId>5462001a6ca3e9.89776785-1</gtr:outcomeId><gtr:partnerContribution>By interlinking complementary biological and computational expertise, the partners aim to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells. By harnessing the capacity of pluripotent stem cells to produce functional cell types with precision and at scale, researchers hope to enable new treatment modalities for degenerative diseases. The PluriMes project is specifically targeted at therapies for muscle, bone and cartilage.</gtr:partnerContribution><gtr:piContribution>Austin Smith is responsible for overall scientific coordination of the project and leads work package 1, translating current advances and understanding of rodent pluripotency to develop and refine conditions that promote homogeneous na&amp;iuml;ve state for human pluripotent stem cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Babraham Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Methylation analyses</gtr:description><gtr:id>C0510710-7117-4536-A8F2-C8AB8ACC798C</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>mHP8XY6f3Ja-1</gtr:outcomeId><gtr:partnerContribution>Methylation analyses</gtr:partnerContribution><gtr:piContribution>Methylation analyses</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Life and Brain GmbH</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>EuroStemCell</gtr:description><gtr:id>87CFC132-BD23-4A5D-8EFB-236BB0AEA55F</gtr:id><gtr:impact>www.eurostemcell.org</gtr:impact><gtr:outcomeId>D4A636509B7-5</gtr:outcomeId><gtr:partnerContribution>EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh</gtr:partnerContribution><gtr:piContribution>Austin is a principal investigator for this collaboration</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Stem Cell Technologies</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>FP7 Project Pluripotent Stem Cell resources for mesodermal medicine (PluriMes)</gtr:description><gtr:id>D024524A-9592-4086-A1EA-F15CCEE9B8CE</gtr:id><gtr:impact>DOI: http://dx.doi.org/10.1016/j.cell.2014.08.029

DOI:10.1038/nprot.2014.102</gtr:impact><gtr:outcomeId>5462001a6ca3e9.89776785-4</gtr:outcomeId><gtr:partnerContribution>By interlinking complementary biological and computational expertise, the partners aim to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells. By harnessing the capacity of pluripotent stem cells to produce functional cell types with precision and at scale, researchers hope to enable new treatment modalities for degenerative diseases. The PluriMes project is specifically targeted at therapies for muscle, bone and cartilage.</gtr:partnerContribution><gtr:piContribution>Austin Smith is responsible for overall scientific coordination of the project and leads work package 1, translating current advances and understanding of rodent pluripotency to develop and refine conditions that promote homogeneous na&amp;iuml;ve state for human pluripotent stem cells.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lund University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>EUROSTEMCELL</gtr:description><gtr:id>6543F987-DCBE-41AC-B68D-0AA1087380F8</gtr:id><gtr:impact>Not given</gtr:impact><gtr:outcomeId>D69578A10AB-2</gtr:outcomeId><gtr:partnerContribution>xxx</gtr:partnerContribution><gtr:piContribution>Austin Smith was the coordinator of this collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>EUROSTEMCELL</gtr:description><gtr:id>9EC6C19C-BCEC-439C-9D5E-C2732A930B54</gtr:id><gtr:impact>Not given</gtr:impact><gtr:outcomeId>D69578A10AB-15</gtr:outcomeId><gtr:partnerContribution>xxx</gtr:partnerContribution><gtr:piContribution>Austin Smith was the coordinator of this collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>EUROSTEMCELL</gtr:description><gtr:id>BD9B1FBB-E8B3-46B1-9584-5302469D6E5B</gtr:id><gtr:impact>Not given</gtr:impact><gtr:outcomeId>D69578A10AB-4</gtr:outcomeId><gtr:partnerContribution>xxx</gtr:partnerContribution><gtr:piContribution>Austin Smith was the coordinator of this collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NsGene A/S</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>EUROSTEMCELL</gtr:description><gtr:id>5CB8D98B-71E4-4F75-97BA-0B690F8CFD7B</gtr:id><gtr:impact>Not given</gtr:impact><gtr:outcomeId>D69578A10AB-13</gtr:outcomeId><gtr:partnerContribution>xxx</gtr:partnerContribution><gtr:piContribution>Austin Smith was the coordinator of this collaboration.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>EuroStemCell</gtr:description><gtr:id>201CDB86-A5DD-44F8-BB6D-BE4B0B904065</gtr:id><gtr:impact>www.eurostemcell.org</gtr:impact><gtr:outcomeId>D4A636509B7-11</gtr:outcomeId><gtr:partnerContribution>EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh</gtr:partnerContribution><gtr:piContribution>Austin is a principal investigator for this collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Swiss Federal Institute of Technology in Lausanne (EPFL)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>EUROSTEMCELL</gtr:description><gtr:id>8BA6446A-F716-4E02-AA69-2AB1FD61852F</gtr:id><gtr:impact>Not given</gtr:impact><gtr:outcomeId>D69578A10AB-11</gtr:outcomeId><gtr:partnerContribution>xxx</gtr:partnerContribution><gtr:piContribution>Austin Smith was the coordinator of this collaboration.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Dando, Weiss &amp; Colucci Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>EuroStemCell</gtr:description><gtr:id>25D3769D-3C90-4F67-85D4-148B9DADFB59</gtr:id><gtr:impact>www.eurostemcell.org</gtr:impact><gtr:outcomeId>D4A636509B7-9</gtr:outcomeId><gtr:partnerContribution>EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh</gtr:partnerContribution><gtr:piContribution>Austin is a principal investigator for this collaboration</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The Roslin Institute</gtr:department><gtr:description>Gene Targeting/ Univ of Edinburgh/ SCI</gtr:description><gtr:id>AB979328-47F2-4236-9434-70A8BCDE753E</gtr:id><gtr:impact>n./a</gtr:impact><gtr:outcomeId>ENhbbh1hJBp-1</gtr:outcomeId><gtr:partnerContribution>Gene targeting by homologous recombination in the rat</gtr:partnerContribution><gtr:piContribution>Gene targeting by homologous recombination in the rat</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>International Summer School, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6DCF2661-8148-4B99-A292-ABEF21F6B952</gtr:id><gtr:impact>University of Cambridge International Summer School, Guest Lecturer

N/A</gtr:impact><gtr:outcomeId>037F837B62B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview, Milwaukee Journal Sentinel</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>820C678C-2CF5-42EC-8995-C06B1928134B</gtr:id><gtr:impact>Interview with Mark Johnson, Milwaukee Journal Sentinel

N/A</gtr:impact><gtr:outcomeId>34720C663D4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Debating Matters, Cambridge</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>97574A9C-B42E-44EC-948E-06F366B16077</gtr:id><gtr:impact>Institute of Ideas and Pfizer Debating Matters Competition, Judge

N/A</gtr:impact><gtr:outcomeId>9603F01BEA7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hosted Nuffield student placement</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E882D110-8B29-43C4-8A7D-EDF5A23C8896</gtr:id><gtr:impact>3 A Level students undertook 4 week research placements to experience working in a laboratory environment. Including talks, tours &amp;amp; visits to several labs. The Smith lab hosted a Nuffield student for 4 weeks. The students were with the lab for 4 weeks and shadowed the scientists in the labs, They also arranged times for the students to read journals and attend seminars. At the end of the 4 weeks, the students had to produce a poster on the work they had conducted over the four weeks. Austin was the overall supervisor for his student, however 4 of his lab members were daily supervisors of the student.

The student in the Smith Lab reported a high level of learning and personal development as well as an increased interest in studying biology. This activity contributes to our strategic objective to engage under-served schools and young people</gtr:impact><gtr:outcomeId>56dd745aaddec1.86004654</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Summer School, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1E29888D-BBE3-4B7E-98FC-D04962B2173B</gtr:id><gtr:impact>University of Cambridge Science Summer School, Guest Lecturer

N/A</gtr:impact><gtr:outcomeId>EB2B3ED462A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>interview in Vienna Standard newspaper</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A8E832AC-7F2E-4791-89BE-B4D7C58D497F</gtr:id><gtr:impact>interview in the Vienna Standard newspaper 3 July, 2013

n/a</gtr:impact><gtr:outcomeId>BFW4nmbGcK6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Plenary Talk, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>87E69404-C78A-441E-9604-9E664CBBF1B0</gtr:id><gtr:impact>Caius Medical Association (approx 60-80 Caius medical alumni), plenary speaker

N/A</gtr:impact><gtr:outcomeId>83912B6C2B3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with Alice Park, Time Magazine</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4059B663-76B0-4F00-A57E-807A3482537F</gtr:id><gtr:impact>increased awareness of Stems Cells in the media

n.a</gtr:impact><gtr:outcomeId>54628adbe5da04.01319619</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Summer School, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DD7079F5-7E1F-4161-80D5-A5D1081D626F</gtr:id><gtr:impact>University of Cambridge Science Summer School, Guest Lecturer

N/A</gtr:impact><gtr:outcomeId>FCD67EAC7E1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview for Agence France Presse</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A9770FBF-D3F7-44D2-9BD9-39C4646F66C3</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>ie4Z8CtcxCy</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cellbound development - Development of the scientific content for a computer game to be used at live events</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BF933208-21AB-43A9-A74A-FDF99A6767B0</gtr:id><gtr:impact>At this pilot event, 20 games developers were offered a crash course in stem cell biology, including a hands-on tour of the laboratories. They then had 48 hours to create a new computer game on the theme 'Destiny &amp;amp; Decisions' in stem cell research.</gtr:impact><gtr:outcomeId>58bead3e0a66c1.08706737</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with BBC Radio Cambridge</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5E23D3D6-9881-4E27-B3B3-FEBC6A8D04B2</gtr:id><gtr:impact>Sparked interest in Stem Cell Biology

n.a</gtr:impact><gtr:outcomeId>54628a7a6aacc4.09685591</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview, New Scientist etc</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9885392D-B59F-4579-B935-99081EB8A3F0</gtr:id><gtr:impact>Follow up interview to the above, New Scientist and other media

N/A</gtr:impact><gtr:outcomeId>358718D0F5D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview, The Guardian</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7DB44BEE-CDDB-420E-ACCF-AA1E4ABCBFD0</gtr:id><gtr:impact>Interview with Sarah Boseley, Health Editor, The Guardian

N/A</gtr:impact><gtr:outcomeId>985E9266483</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Staff Engagement Talks</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B86066C4-02C6-46AC-93B6-B323A3E427C2</gtr:id><gtr:impact>Research explained to the Admin team of the Cambridge Stem Cell Institute.</gtr:impact><gtr:outcomeId>58beae3da38de5.75994093</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Stem Cell Podcast</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>173A4827-8B8F-4E88-896F-500D3ADB75F3</gtr:id><gtr:impact>The interview was for the Stem Cell podcast which is listened to by more than 20,000. This was a great platform to discuss a recently published paper which allowed a wide audience to receive information about the paper.

Increase awareness of the published paper</gtr:impact><gtr:outcomeId>5464972961f739.32356276</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to Biomedical Students from Utrecht who were visiting the UK</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>20505E23-1D76-4E07-8C0D-C4D2AD60380B</gtr:id><gtr:impact>A group of 50 final year undergraduate and masters students interested in stem cell and regenerative medicine research

To give them and impression of stem cell and regenerative medical research work at an international university for making choice in their academic careers.</gtr:impact><gtr:outcomeId>qLYvyc1nvWp</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Summer School, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4888A551-6C2E-4FFA-8021-5F848F9FD055</gtr:id><gtr:impact>University of Cambridge International Summer School, Guest Lecturer

N/A</gtr:impact><gtr:outcomeId>134B74DDC9A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Culture as Professional Science, London</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>87484020-3620-420F-9D77-05059DEB8622</gtr:id><gtr:impact>LSEPS, Interview for SCOPE (Scientists on Public Engagement: from communication to deliberation), interviewee

N/A</gtr:impact><gtr:outcomeId>BA247A66228</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Summer School, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1E255CCD-434B-4B66-97CA-CA9456CA49E7</gtr:id><gtr:impact>University of Cambridge International Summer School, Guest Lecturer

N/A</gtr:impact><gtr:outcomeId>E3EC33523D0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview, The Sun</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1670EFD1-1EE6-4412-9596-F57BF4A6091D</gtr:id><gtr:impact>Interview with Jane Symons, Health Correspondent, The Sun

N/A</gtr:impact><gtr:outcomeId>5B48FF57943</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with Fabian Ketschmer, Der Standard</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>285E912E-A3E5-4205-A07F-ED65F9B0B239</gtr:id><gtr:impact>Increased awareness of the UK Stem Cell Science developments

n.a</gtr:impact><gtr:outcomeId>5464a22eb78e13.31479544</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Discovery - The Stem Cell Story, BBC World Service</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>66B1817E-3D1F-4E81-89F5-4A68E72CED1B</gtr:id><gtr:impact>Interview with Sue Broom, presenter of &amp;quot;Discovery - The Stem Cell Story&amp;quot; on BBC World Service

N/A</gtr:impact><gtr:outcomeId>55E7B06B2C2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science uncovered at the Natural History Museum</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8AC16E8D-1107-4DE4-8FB7-7A0238C97BB2</gtr:id><gtr:impact>Masaki Kinsohita from the Smith Lab (Post doctoral researcher). For one evening only, the Natural History Museum will be taken over by scientists! Interactive activities and exhibits throughout the museum will provide an opportunity to learn about the latest research 
 Outcome: This activity contributes to our strategic objective to engage hard to reach adults</gtr:impact><gtr:outcomeId>56dd76c0e54ce4.57318037</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F3D6F611-986C-4CC5-B8DE-4B136BE29049</gtr:id><gtr:impact>800 A-level biology students attended a lecture on Stem Cell Research as part of their annual programme which is called 'A Student's Guide to DNA and Genetics'.

After providing a similar talk in 2009 The Institute of Education in London requested a return lecture.</gtr:impact><gtr:outcomeId>q9XiahqJH3Z</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DD13FAA7-4535-4953-9A8C-2F6E5415E821</gtr:id><gtr:impact>Public presentation on Stem Cells 'Hope or Hype' as part of the Cambridge Science Festival

n/a</gtr:impact><gtr:outcomeId>mKZoPvCemcc</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cardiff Scientific Society</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E401E92F-D3C9-4446-82E7-F923C7D5FFC5</gtr:id><gtr:impact>Presented the Sir Martin Evans Lecure to Cardiff Scientfic Society members.

n/a</gtr:impact><gtr:outcomeId>kF7L63zjCeL</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Summer School, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7031E218-2314-4C4F-8772-6EA29A00FA19</gtr:id><gtr:impact>University of Cambridge Science Summer School, Guest Lecturer

N/A</gtr:impact><gtr:outcomeId>85C8CC36326</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Regenerative Medicine - a new frontier for therapeutic intervention, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>85E25AED-B912-4FEA-BDCA-BA0C65545F44</gtr:id><gtr:impact>The Society of Medicines Research, speaker

N/A</gtr:impact><gtr:outcomeId>F1B6FBB0A17</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge ideas that could change the world, Cambridge</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>08785AB0-62B9-4404-A4F7-528CDAB0BAA4</gtr:id><gtr:impact>Cambridge Network Open Meeting

N/A</gtr:impact><gtr:outcomeId>2ED94AFDB47</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Summer School, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>583EDCEC-0FA5-42BF-AB8B-7202EF62EFE2</gtr:id><gtr:impact>University of Cambridge Science Summer School, Guest Lecturer

N/A</gtr:impact><gtr:outcomeId>F5D5EC8B5D6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Post-doc careers workshop, Warwick</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>05BD4DD9-2E23-4E37-AA0D-DD8AF1E997BB</gtr:id><gtr:impact>Post-doc careers Workshop @ University of Warwick, British Society of Cell Biology, Session Chair

N/A</gtr:impact><gtr:outcomeId>13AE8D99F3B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>25 Years of Embryonic Stem Cells in Cambridge</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>ED465623-D1D3-45E0-97D1-68EEA3B5591B</gtr:id><gtr:impact>Discussion post event</gtr:impact><gtr:outcomeId>5464c88b911b66.45440190</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Speaker at 'See inside the Cambridge Stem Cell Institute' 2015</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3762D728-8A41-476B-8858-34F15B464BA9</gtr:id><gtr:impact>15 members of the general public were invited to the Stem Cell Institute for a tour of the facilities. Members of the Smith Lab showed the general public around the lab space and gave demonstrations about the different facilities we have on site. Austin Smith gave an introduction to the tour group about the Institute and also did a question and answer session at the end,</gtr:impact><gtr:outcomeId>56dd6f4f3c7b57.39444840</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Game Jam - Smith Lab</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A7094442-B29F-4071-A9C8-7A81E4EE03C2</gtr:id><gtr:impact>At this pilot event, 20 games developers were offered a crash course in stem cell biology, including a hands-on tour of the laboratories. They then had 48 hours to create a new computer game on the theme 'Destiny &amp;amp; Decisions' in stem cell research. Members of the Smith lab took the game developers on a tour of the lab and provided them with the crash course of stem cells. The smith lab members were also available on the day to answer questions or help provide scientific content.
 Outcome:
 This activity contributes to our strategic objective to engage hard to reach adults</gtr:impact><gtr:outcomeId>56dd7669c42be5.42019330</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>An Interview with Austin Smith</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F82BD9C9-8C07-4A8F-9F90-3CBA6C0DC9DB</gtr:id><gtr:impact>An interview piece by Caterina Vicente, originally publised in Development; republised by, The Node &amp;amp; EuroStemCell and widely shared on Twitter.
 Outcome:
 This activity contributes to our strategic objective to engage hard to reach adults</gtr:impact><gtr:outcomeId>56dd75498fef09.63345782</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nuffield Research Placement</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D107B0F2-C7A5-47CC-A856-A6769F789F8A</gtr:id><gtr:impact>Sixth-form student completed a 4-week placement in the Smith Lab.</gtr:impact><gtr:outcomeId>58beadced15452.07761665</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pint of Science 2015</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>93216DF8-2B2C-4C35-92BB-0E3A01A10F51</gtr:id><gtr:impact>Pint of Science hosts scientific talks and events in various pubs around the world. There were several venues in Cambridge, but the main stem cell talks were at the Panton Arms. Stanley Strawbridge (PhD student in the smith lab) was on the committee and helped organise the talks across Cambridge. He was also responsible for promoting the event to the general public.</gtr:impact><gtr:outcomeId>56dd6fe944bc45.30234472</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview for the University of Cambridge Radio</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E9187586-85A9-4AFC-A152-3E2E259B9DF5</gtr:id><gtr:impact>Interview for the University of Cambridge Radio Station

Promoted the work of the Stem Cell Institute</gtr:impact><gtr:outcomeId>54649650555767.92287477</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>CD1965D0-A6FB-43D3-AE31-83EAAC8453CC</gtr:id><gtr:impact>120 public attended the presentation and slide show. There was a Q&amp;amp;A at the end of the talk.

n/a</gtr:impact><gtr:outcomeId>ARo9fsuCehe</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Network Meeting, Melbourne, Australia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3ECAE0A0-314E-4AA0-AAEE-349AF009C029</gtr:id><gtr:impact>TeamVIC Network Meeting

N/A</gtr:impact><gtr:outcomeId>50D8996CEE0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC/MRCT promotion, Tokyo</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9CFC6BA7-2B14-4086-83C0-182623C95058</gtr:id><gtr:impact>Raise the Profile of MRC Funded Science in Japan, British Embassy

N/A</gtr:impact><gtr:outcomeId>3C1C2E21A29</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Authored materials for EuroStemCell</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EF4FBEE8-C372-4E48-8968-3F6647703488</gtr:id><gtr:impact>Professor Austin Smith authored materials for EuroStemCell. These were used on their website which is a source of information about Stem Cells. This website is promoted to the general public.</gtr:impact><gtr:outcomeId>56dd6e0b8c22b6.73523978</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture, Edinburgh</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>13B37BEA-8613-4BFD-8BD3-B4F606640D18</gtr:id><gtr:impact>Lecture for the Office of Lifelong Learning, University of Edinburgh

N/A</gtr:impact><gtr:outcomeId>3F8F12972C7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival 2015</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2A81585A-BF54-4D89-94F5-FA1C3F90352C</gtr:id><gtr:impact>Ge Guo and Sam Myers from the Smith Lab took part in the Cambridge Science Festival 2015 - the theme was Differentiate Me.
 'Differentiate Me' was a hands on exhibit at the Cambridge Guildhall designed by SCI researchers. It involved 3 activity stations, suitable for a wide age-range, all of which aimed to teach the fundamental principle of differentiation:
 Cell transformers - a mock wet lab activity where children dress in lab-coats and goggles
 The Blood Station - modelling different types of cell in play-doh
 Race to Differentiate - a multi-player custom designed board game
 Outcome:
 We had positive face-to-face reactions with hundreds of children and their families, which helps to meet our strategic objective to engage Cambridge families.</gtr:impact><gtr:outcomeId>56dd6eab6d8a80.97915900</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview for AAAS - Science Magazine, Berlin</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2D53BECE-9049-4998-A3A9-72F6C540872A</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>ScvtaatCb1u</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science in Society, Paris</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D717D61C-B9DF-4D50-A6D6-0702AF4B39B7</gtr:id><gtr:impact>Ministere De Leenseignment Superieur, Science in Society

N/A</gtr:impact><gtr:outcomeId>87253F89D6C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with Anna Azvolinsky, Science</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F052C504-A2CA-45F3-B761-800F414E7DB6</gtr:id><gtr:impact>Spread information about the Stem Cell Institute

n.a</gtr:impact><gtr:outcomeId>54649874042cb3.60600845</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Rachford Lecture - Cincinnati Children's Hospital</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4096BB5E-3BE2-4692-BFA0-47D8FCB789E8</gtr:id><gtr:impact>Large question and answer session after the talk - talk promoted in depth discussions

n.a</gtr:impact><gtr:outcomeId>5464a3c050e600.39300041</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>AbCam - Rediscovering Pluripotency</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6F9522FD-DA30-4587-B357-D4C0E82CEE52</gtr:id><gtr:impact>The talk encouraged thinking and discussions

n.a</gtr:impact><gtr:outcomeId>5464a7da00f453.31878051</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.abcam.com/index.html?pageconfig=resource&amp;rid=13408</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit from MEP</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8582C651-7C40-47D1-9072-C0730AD595BB</gtr:id><gtr:impact>Vicky ford, MEP was interested in meeting to discuss the ECJ ruling on patents for Stem Cell Research

Ms Ford has asked for a follow-up meeting.</gtr:impact><gtr:outcomeId>m8MLUhdwvuN</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dinner at the British Embassy, Switzerland</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1CF52FF8-8FB2-4C5E-829F-014A58232892</gtr:id><gtr:impact>n.a</gtr:impact><gtr:outcomeId>5464aa28ac4562.80558292</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A Student's Guide to DNA and Genetics, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0991F2FF-9676-4AE4-9C9A-130BB17F92B1</gtr:id><gtr:impact>Talk to 900 A-level students, The Training Partnership, Institute of Education, speaker

N/A</gtr:impact><gtr:outcomeId>126D75022E0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open Meeting, Edinburgh</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E11C84B0-50C0-4457-A4D8-5ED624A299B5</gtr:id><gtr:impact>Open meeting on Public Engagement on Stem Cell Research, panel member

N/A</gtr:impact><gtr:outcomeId>DF611A040A0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Comparing iPS cells and hES cells, Lund, Sweden</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B5312782-5F9A-4C62-BA69-6781EF33A7F5</gtr:id><gtr:impact>ESTOOL: Ethical Aspects of Research on Interspecies Embryos and IPS Cells, Panel participant

N/A</gtr:impact><gtr:outcomeId>F00C851955B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A Stem Cell Story, Edinburgh</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2ACC010C-6D2F-49F5-A4C8-5ABDEFF1DBA3</gtr:id><gtr:impact>Editorial advisor and contributor to the animated film, &amp;quot;A Stem Cell Story&amp;quot;

Best TV/video production, Troms&amp;oslash; Science Media Festival
Best short film, Scinema (Australia)
In competition, Science Film Festival (Bangkok), BaKaFORUM 2007, Vedere la Scienza</gtr:impact><gtr:outcomeId>22FF6C53D2D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alumni Weekend, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>73AD7D37-6C77-425F-BA2A-09E6C380E456</gtr:id><gtr:impact>Alumni Weekend, Newnham College, Cambridge, Speaker

N/A</gtr:impact><gtr:outcomeId>A3D2E3BB045</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media Round Table, Amsterdam</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>04A7D37F-7451-4FA2-9248-ED692BD6651B</gtr:id><gtr:impact>&amp;quot;Stem cells: the next 20 years; natural versus induced pluripotency&amp;quot;, EMBO, Amsterdam

N/A</gtr:impact><gtr:outcomeId>033A9F27A94</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with Heart Radio</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>587139C5-DDB1-4C7A-8EAF-C998350CA400</gtr:id><gtr:impact>Interview with the local radio station to discuss Stem Cells and the work being done in this field

Increased awareness of the work being done in Cambridge in the Stem Cell field.</gtr:impact><gtr:outcomeId>546495df16c914.35343353</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Photoshoot - 'The Philanthropist' magazine</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>64ED7FC9-35B7-490A-861F-2DB65230947C</gtr:id><gtr:impact>An interview and photo-shoot for Cambridge University's 'The Philanthropist' magazine - a feature about the work of the Cambridge Stem Cell Institute

Increased awareness of the work of the Cambridge Stem Cell Institute</gtr:impact><gtr:outcomeId>546495379543f4.42949714</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A Stem Cell Story, Edinburgh</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A6A62643-2C54-478C-9C00-6F7DCCC938D6</gtr:id><gtr:impact>Work on animated film &amp;quot;A Stem Cell Story&amp;quot; for EuroStemCell.

N/A</gtr:impact><gtr:outcomeId>C9D5C92D9AA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with Rob Stein, NPR</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8BBA2949-1132-4CA9-85BE-B6106003A6AE</gtr:id><gtr:impact>Increased awareness around Stem Cell Biology

not known</gtr:impact><gtr:outcomeId>54628a214e9503.87129173</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Growing Businesses with Stem Cells, Cambridge</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>35743F47-97D4-4B8F-9FBF-66D7D4CFFA11</gtr:id><gtr:impact>CULIL/EESCN

N/A</gtr:impact><gtr:outcomeId>E43BC7BABDD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parliamentary Office of Science and Techonolgy, London</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4C5E83B8-98F9-48A7-B8E1-FEAE3D43D3E4</gtr:id><gtr:impact>Considering the scientific developments in stem cell research in last ten years, specifically:
1. ESC lineage restriction and induction of differentiation to produce specific cell types (lineage programming)
 2. Scientific developments in cell transplantation, specially ESC-derived neuronal cells to treat neurodegenerative diseases
3. The potential of ESCs in cell replacement therapies
4. potential/limitations of iPSC research concerning therapeutic applications
5. Whether iPSC are equivalent to ESCs
6. Fundamental research on ESC is it necessary
7. Future outcomes for stem cell research

Meeting was with Parliamentary Adviser Dr Mara Almeida</gtr:impact><gtr:outcomeId>PgWRmc8LmDh</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press Round Table, Dresden</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A2B3D272-F604-4D10-BB45-D199A3FA5F1F</gtr:id><gtr:impact>Press Round Table, 2nd International Congress on Stem Cells

N/A</gtr:impact><gtr:outcomeId>911090548DD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to 6th Form Students, Canterbury</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E13E6F81-61FC-4913-BC49-B54D42FFBCDF</gtr:id><gtr:impact>Talk to 6th Form students, Simon Langton Grammar School for Boys, Speaker

N/A</gtr:impact><gtr:outcomeId>50B3BC85879</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The layman challenge 'explaining work to a group of non-scientists'</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EBA18C5A-D978-4F74-A9C0-0FFB0B139D04</gtr:id><gtr:impact>Professor Smith took part in the The layman challenge. He had to explain his work to a group of non-scientists, this was so the general public could understand his research without needing a scientific background.</gtr:impact><gtr:outcomeId>56dd75ba7f18c4.40545435</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Engagement Workshop - Wellcome Trust</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1209BDC4-EBB2-44FC-93BB-AB4E12DB8B80</gtr:id><gtr:impact>sparked discussion of the issues facing regarding public engagement and how the Wellcome Trust could help to overcome difficulties or barriers.

n/a</gtr:impact><gtr:outcomeId>A7nKfQ4StJx</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxbridge Academic Programmes - Tour</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8C6766F7-9037-4B7A-9651-F6F4E812A709</gtr:id><gtr:impact>15 sixth form students were invited for a lab tour of the lab. Stanley Strawbridge (Smith Lab) showed the student around the lab and talked them through the work which is conducted in the smith lab.</gtr:impact><gtr:outcomeId>56dd74f2949b12.72834963</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Summer School, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>36CB99E3-17B3-4466-8105-DE16A1EE1ED7</gtr:id><gtr:impact>University of Cambridge International Summer School, Guest Lecturer

N/A</gtr:impact><gtr:outcomeId>F0B4885236D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with The Asahi Shimbun</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DB504670-C28C-4FAB-92FC-377E46848185</gtr:id><gtr:impact>The Asahi Shimbun is one of the five national newspapers in Japan - after the interview this promoted the relationship between Stem Cell Science in the UK and Japan

Increased awareness of UK Stem Cell Science in Japan</gtr:impact><gtr:outcomeId>5464a1e394c1d5.76563413</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture at Croucher Foundation Advanced Study Institute</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9052EF37-C8B4-4757-9193-7BC280131021</gtr:id><gtr:impact>Lecture prompted discussions and questions

Have been invited back in Jan 2014 to present again</gtr:impact><gtr:outcomeId>5464a476601de3.34061140</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Judge at the game jam</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>462008D9-385B-409F-8841-C2C506F133C1</gtr:id><gtr:impact>At this pilot event, 20 games developers were offered a crash course in stem cell biology, including a hands-on tour of the laboratories. They then had 48 hours to create a new computer game on the theme 'Destiny &amp;amp; Decisions' in stem cell research. Austin Smith was on the judging panel.
 Outcome:
 This activity contributes to our strategic objective to engage hard to reach adults</gtr:impact><gtr:outcomeId>56dd760ff0bb00.95868389</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk Science, British Library, London</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>91F37B12-5D2B-44B0-9221-520FCEE4C925</gtr:id><gtr:impact>Presentation and discussion at the British Library, audience including researchers and scientific stakeholders

N/A</gtr:impact><gtr:outcomeId>69391CAE0FF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Filmed interview -  cell therapy</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6BF686F8-F8C6-49C9-8E33-0059981A15E1</gtr:id><gtr:impact>Interview encouraged discussions

n.a</gtr:impact><gtr:outcomeId>5464ab0e533472.50908366</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview, BBC Radio, Cambridge</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EC0AC200-1344-44C9-8807-202E781C6A61</gtr:id><gtr:impact>Interview on peer review with Palab Ghosh, BBC Radio

N/A</gtr:impact><gtr:outcomeId>ACD6FA996D6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Youth Science Parliament, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>37349549-130F-4914-961E-03DB53EBEAC5</gtr:id><gtr:impact>Presentation and discussion with 15-20 6th Form Students

N/A</gtr:impact><gtr:outcomeId>07C51205FDA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Literary Festival 2014</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9213BA8C-9E3F-4295-B39D-EDB268DFEE90</gtr:id><gtr:impact>The talk resulted in increased interest in the work of the Stem Cell Institute

Asked for participation in the next event</gtr:impact><gtr:outcomeId>5464a3215a63e0.65034518</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting with Dr Evan Harris, Liberal Democrat Shadow Science and Innovation Minister</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>686308EC-AF31-488E-8542-6CDDE6D39DAB</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>dvmnMiJifLk</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Stem Cells and their Secrets, Cambridge</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E3379534-4BC8-4347-945C-232D85FF6CFD</gtr:id><gtr:impact>JDRF Cambridge Open Day.

N/A</gtr:impact><gtr:outcomeId>1425BC3A066</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Documentary, Edinburgh College of Art</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6BCB3CF5-20AA-41FE-8912-DBFC49EF3445</gtr:id><gtr:impact>Filming 'The Definitive Story of Stem Cells' (working title)

N/A</gtr:impact><gtr:outcomeId>D9D42732783</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>192A4AD0-5C2A-47F4-9C84-D0E67CB71351</gtr:id><gtr:impact>Cambridge Society for Applied Research, lecturer

N/A</gtr:impact><gtr:outcomeId>7DD022B00A7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit, Edinburgh</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>35551FF7-FDF0-4BA9-A1FD-566DC662E73F</gtr:id><gtr:impact>Presentation and discussion on stem cell, St George's School for Girls, presenter and discussion leader

N/A</gtr:impact><gtr:outcomeId>9165B559DCC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Ideas to Reality, Cambridge</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F2650ACF-644A-4B41-83D9-804F2D7A02FD</gtr:id><gtr:impact>Cambridge Enterprise

N/A</gtr:impact><gtr:outcomeId>599E1A3BDBF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cell Therapy, Filmed Interview</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A932DEA5-BB03-4055-B435-E5E33F578999</gtr:id><gtr:impact>JDRF Centre for Beta Cell Therapy in Diabetes, interviewee

N/A</gtr:impact><gtr:outcomeId>57B5E1325AB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>43902</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Steering Embryonic Stem Cells towards Pancreatic</gtr:description><gtr:end>2010-04-02</gtr:end><gtr:fundingOrg>Juvenile Diabetes Research Foundation (JDRF)</gtr:fundingOrg><gtr:id>50C9AAEF-13CD-4D84-A8EA-E6454EE8BFB2</gtr:id><gtr:outcomeId>5828F1EBB180</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>38175</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EUROSTEMCELL: European Consortium for Stem Cell Research (0.8m euros across 11 participants)</gtr:description><gtr:end>2008-01-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>7E131E54-DE31-4E17-85A5-BE9D4039A934</gtr:id><gtr:outcomeId>B5B0CBC01600</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>56594</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Japanese Partnership</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>3932D4E8-6062-4439-9BA9-5C5372D477B8</gtr:id><gtr:outcomeId>23BB2336DBB0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>795134</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Centre for Stem Cell Biology &amp;amp; Regenerative Medicine</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>3FC9F2BC-36BC-4482-A64B-D8416E859B3C</gtr:id><gtr:outcomeId>28F0A1B857D0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6457</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EUROSTEMCELL: European Consortium for Stem Cell Research (0.8m euros across 11 participants)</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>D997487B-0E0D-45E0-9423-C2498F1548AC</gtr:id><gtr:outcomeId>746AEB0D6440</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>652985</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NeuroStemcell Project - European consortium for stem Cell therapy</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>5C9156D4-1CE0-4AEE-AED8-EDB50A7A19F8</gtr:id><gtr:outcomeId>3F2A5D691470</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>26596</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Transplantation protocols to assess the ability of ES cell derived endodermal populations to differentiate towards pancreatic lineages</gtr:description><gtr:fundingOrg>Juvenile Diabetes Research Foundation (JDRF)</gtr:fundingOrg><gtr:id>1EB25DB5-78AF-4531-99F4-99166CE2FEE7</gtr:id><gtr:outcomeId>023525F45670</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>102527</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Embryonic Stem Cells, Neural stem cells and Neurons</gtr:description><gtr:end>2009-05-02</gtr:end><gtr:fundingOrg>Fidelity Biosciences</gtr:fundingOrg><gtr:id>587C4039-976E-4D01-AD78-B8CBE3B03D59</gtr:id><gtr:outcomeId>59F3CF241400</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2007-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>279872</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Stem Cell Career Development Fellowship</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>8521AD5E-CAB2-4ACF-B6A6-983568B26035</gtr:id><gtr:outcomeId>12C5738D3C60</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>177218</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Regulation of Self Renewal, Commitment and Differentiation in Brain Cancer Cells</gtr:description><gtr:end>2011-05-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>E84DF787-C9DB-4598-90C5-93B4B7594211</gtr:id><gtr:outcomeId>F411D298D5E0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Addenbrookes Charitable Trust award of Consumables for Dr. K.Kurian to work within Biochemistry: Stem Cell Institute</gtr:description><gtr:fundingOrg>Addenbrooke's Charitable Trust (ACT)</gtr:fundingOrg><gtr:id>F8F6E5C6-BD5F-428B-8C2E-83F04FE35EF5</gtr:id><gtr:outcomeId>EAF7BBF1B560</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>612215</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BB/H012737/1 Gene Targetting by homologous recombination in the Rat</gtr:description><gtr:end>2015-05-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/H012737/1</gtr:fundingRef><gtr:id>EA41626B-01A7-4508-80C5-EE2CFAE468FD</gtr:id><gtr:outcomeId>2D4521538430</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6956531</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Core Support for Wellcome Trust Centre for Stem Cell Research</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>76AAEDD1-BDA9-4CC5-938F-91E297921076</gtr:id><gtr:outcomeId>00DACD70C7F0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>517672</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EURATRANS European large-scale functional genomics in the rat for translational research (10.5m euros across 19 participants)</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>3806D140-8E57-4845-9F2C-B7586F0B7B38</gtr:id><gtr:outcomeId>CA862B78D080</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>55624</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Characterisation of new human ES cell derived in novel</gtr:description><gtr:end>2007-12-02</gtr:end><gtr:fundingOrg>Juvenile Diabetes Research Foundation (JDRF)</gtr:fundingOrg><gtr:fundingRef>4-2005-821</gtr:fundingRef><gtr:id>576B9679-7380-4ABD-9979-AD0DF8512596</gtr:id><gtr:outcomeId>4D46BD57FE60</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>374310</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SyBoSS Project - Systems Biology of Stem Cells and Reprogramming</gtr:description><gtr:end>2015-05-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>CBB54028-7689-447B-A8C7-D0077E74397B</gtr:id><gtr:outcomeId>01B17BA0A080</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Summer Studentship for Magdelena Stasiulewicz</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>9E4120B8-52C9-4540-8A1A-DDABC848697B</gtr:id><gtr:outcomeId>2F200E9C86F0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1143873</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Stem Cell Initiative (Core Grant)</gtr:description><gtr:end>2008-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>CDACDD2A-F648-4A38-86E1-A48C58780472</gtr:id><gtr:outcomeId>FFAD3305C510</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>823424</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BetaCellTherapy: Beta Cell Therapy in Diabetes</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>510E6B87-4B14-4EBC-AC91-F6A886A5ED90</gtr:id><gtr:outcomeId>B5FDB59682E0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Collaborative bursary MiRNA expression in brain cancer stem cells</gtr:description><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>4F527D77-DEEB-4CE6-B5AC-2E7037900500</gtr:id><gtr:outcomeId>16087D28D080</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>195139</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The Discovery of future Neuro-therapeutic Molecules (NEUROscreen)</gtr:description><gtr:end>2010-07-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>2A5D8AF3-16DB-4527-A55B-0400B04C7A49</gtr:id><gtr:outcomeId>908ED1D1B160</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1736222</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The Road from Pluripotency to Lineage</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>A0CC096F-56B5-46AA-A81E-E63B4E52762E</gtr:id><gtr:outcomeId>5AFC2BBA60F0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1511268</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Plurimes - Pluripotent Stem Cell Resources for Mesodermal Medicine</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>D1BFE76D-0DED-4CA2-96CD-37429E5CCB17</gtr:id><gtr:outcomeId>54648c6eb85941.64212951</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1211904</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The Stat3 pathway in Stem Cell Self renewal and the germline</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>E7C413BE-9191-4AA6-B26C-C2C992DE3B09</gtr:id><gtr:outcomeId>3CED8B6DB870</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>22500</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Ole Wiskow Studentship</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>C94F6773-25FD-4BFF-B536-08D10DDD4515</gtr:id><gtr:outcomeId>497CC9D8FAF0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>844000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Regulation and function of the pluripotency determinant Nanaog</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>ABB60B6F-F2B9-45F3-AA57-90E9B1FC4EB7</gtr:id><gtr:outcomeId>E979C6E841F0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>841267</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Stem Cell Potency</gtr:description><gtr:end>2008-02-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>DE66B8CD-0DF5-4A18-A2C1-C19DECF9FC67</gtr:id><gtr:outcomeId>ECF7D8FA76A0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>126043</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome-Beit Prize Fellowships</gtr:department><gtr:description>Beit Memorial Fellowship for Medical Research</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>F2096CFB-898A-4B94-881D-5A2E64F818B4</gtr:id><gtr:outcomeId>F589A3CCF1C0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>373970</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ESTOOLS: Platforms for Biomedical Discovery with Human ES cells</gtr:description><gtr:end>2010-07-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>8E100D67-86BD-44DD-B2FD-76BCEC66E76A</gtr:id><gtr:outcomeId>712853A95590</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>294553</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Stemstroke: Towards a Stem Cell Therapy for Stroke</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>33234D17-B0B0-4D8A-A7BB-14FDBB5759A2</gtr:id><gtr:outcomeId>A5E10F067750</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1184402</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EUROSYSTEM European consortium for systematic stem Cell Biology (12m euros across 24 participants)</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>B49DC02F-1A8B-4240-9285-4BB730523FC6</gtr:id><gtr:outcomeId>858521D11E70</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>52827</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Precision Transgenesis in Rats via Embryonic Stem Cells</gtr:description><gtr:end>2009-01-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>0AA39175-39A8-4F80-BDB5-32E50F694740</gtr:id><gtr:outcomeId>E43A9607CB00</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>n.a</gtr:description><gtr:grantRef>G1001028</gtr:grantRef><gtr:id>D4963219-4EB0-4BB2-9F91-7B8EFF452666</gtr:id><gtr:impact>n.a</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>56dd9129498e12.02269795</gtr:outcomeId><gtr:protection>Patent application published</gtr:protection><gtr:title>Resetting pluripotent stem cells</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MEP Forum - Brussels</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>0E9735EA-5D82-4AFF-837F-C79E3450967A</gtr:id><gtr:outcomeId>E3FznB6aCwB</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Briefing of Wellcome Trust Policy Advisor</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E1FD872E-9756-48C5-99B3-7744EBCBD6EE</gtr:id><gtr:outcomeId>56dd784dbac4e3.09700090</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>REVIVE Stem Cell Network</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>D21C2DD7-7B2C-4F3D-BE60-A6E9F63FEEBE</gtr:id><gtr:outcomeId>X1VJX1iXvhi</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Wellcome Trust Meeting - Embryonic Stem Cell Research:Beyond Brustle v Greenpeace</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>B38E32A2-456B-43D0-80F5-C462A712EE9E</gtr:id><gtr:outcomeId>jicZfAncogC</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Meeting with iPS Cell Surveillance Project, Japan Science and Technology Agency</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>2789D575-99AE-43A3-AA2B-525825487775</gtr:id><gtr:outcomeId>B3DDBEDD586</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advisory board member for: Izmir Biomedicine and Genome Center, Dokuz Eylul University, Turkey</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>AFF5D999-1839-458C-89C1-A778930671C2</gtr:id><gtr:outcomeId>56dd789ba3bf74.49480964</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>CiRA Symposium, Kyoto</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>0894380A-1B08-449A-9232-7FE3CDD8FBAA</gtr:id><gtr:outcomeId>VAMFnUVXC4b</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EMBO Science and Society Report on Stem Cell Research</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>E26B4B73-48A5-4DD6-81F8-400019239E06</gtr:id><gtr:outcomeId>7656D004377</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>European Court of Justice decision on patents on Embryonic stem cell research</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>431265AE-0993-44B3-9D11-38631C4B61A0</gtr:id><gtr:outcomeId>RxLzTwH1FQf</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Erasmus University Medical Centre, Stem Cell Initiative for Regenerative Medicine, international External Scientific Advisory Board</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>9A789BCD-61A0-45D9-B480-A099648E1DB8</gtr:id><gtr:outcomeId>534E931087D</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>G-COE Advisory Board</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>77EC17F6-2968-4C9D-B669-A70E710C3936</gtr:id><gtr:outcomeId>988689542E8</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Briefing of Policy Advisor</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B0B1B755-DA3C-475B-8EAF-2C29D1D640CC</gtr:id><gtr:outcomeId>pdjYMDcsuLw</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Hubrecht Institute International Eveluation Committee</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>66F84494-9B9A-4EF0-A55D-3C5256B510D0</gtr:id><gtr:outcomeId>C67CF34F4D1</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>UK Stem Cell Bank Management Committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>359E5D15-64EC-49C2-9E7D-7F7A12E9F4EE</gtr:id><gtr:outcomeId>9504A320741</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EMBO Advisory Board Meeting</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>A02252E9-57C6-4F54-A0C1-62DC297BA85D</gtr:id><gtr:outcomeId>awTWK9T8sq7</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>UKSCB Advisory Board</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F17C728F-8059-48F5-B8C0-9FB2E605D5F5</gtr:id><gtr:outcomeId>cbkTSWg5kts</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MEP Briefing</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>7C1FB4F7-828B-4F49-BA12-95667E1BAD7F</gtr:id><gtr:outcomeId>fkLYKmxHHky</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC-Chinese Academy of Sciences Workshop</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>B6A145E2-4381-4311-BD57-F9D171458F18</gtr:id><gtr:outcomeId>647ECE1A579</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ISSCR Board of Directors Meeting</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>5C6F8994-60C0-4EBD-BB5E-75DA0B750B1F</gtr:id><gtr:outcomeId>5460f41e1b7061.47516754</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ISAB Meeting</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>59F47C3A-5D89-4772-A87E-587EB599321F</gtr:id><gtr:outcomeId>QmJxULA3wuH</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>UKRMP Advisory Board</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4961233F-F4DA-4963-8500-1C8E04BBBAA1</gtr:id><gtr:outcomeId>c5hEjCQ5ph7</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Wellcome Trust Sanger Institute Cellular Genetics Programme</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>EAF81BC3-BF5C-4C6E-B5B8-C3505A67CD97</gtr:id><gtr:outcomeId>56dd791eb93a52.63470857</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>House of Commons Science and Technology Committee Consultation</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E7EEE69C-99E0-4B4C-B7F6-65F672A0DB34</gtr:id><gtr:outcomeId>FC6751686E6</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>International Scientific Advisory Board Annual Meeting 2014</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>334962D8-7A0B-4F0C-BE59-808D51710143</gtr:id><gtr:outcomeId>5460f37186c9a9.23200379</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>CiRA Symposium, Kyoto</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>DAC593CD-5F43-4ECE-8BCC-6C74A38D60A2</gtr:id><gtr:outcomeId>5460f298da0309.35069806</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Global COE programme, Kyoto</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>8BC8C75E-1F4A-427B-A2BD-DFA5AF452610</gtr:id><gtr:outcomeId>XFnLhZWwWMo</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>AstraZeneca, Stem Cell &amp;amp; Primary Cell Scientific Advisory Board, Sweden</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>754B9422-8D39-4AE8-AF8C-3EF06F28D74E</gtr:id><gtr:outcomeId>56dd786fbf6209.42452346</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Cell Therapy Catapult Academic Advisory Board, London, UK</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>27A95737-EF7F-48F6-BF0F-204C3F1AE74C</gtr:id><gtr:outcomeId>56dd78f2ad0ba9.12249881</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>CDB</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E8045F96-1EEA-4FED-AB4A-31F20F108815</gtr:id><gtr:outcomeId>KVgt85zHToX</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ISSCR - keynote speaker</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E410F0A6-1388-40EC-BA11-B170167ED500</gtr:id><gtr:outcomeId>AbwH5NG49r7</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>RIKEN Advisory Council</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>451AD34E-A530-4DB9-8729-E1D4D317D5BE</gtr:id><gtr:outcomeId>D9419C7B26D</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ISSCR Advisory Board</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>CDA7E981-1576-4F23-9887-F0B617E046A6</gtr:id><gtr:outcomeId>dsv4NdHwkQZ</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EMBO Membership Committee</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>16C7EED8-D149-46BE-B884-1872DCEA72B3</gtr:id><gtr:outcomeId>910811B7AF9</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Briefing of Wellcome Trust Policy Advisor - Dr Alexis Gilbert</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6A9EE6C4-FC69-4833-90E6-7E85EDDB22A2</gtr:id><gtr:outcomeId>56dd793c438d21.85956289</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>OICR Cancer Stem Cell Program, Scientific Advisory Board</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>E5DFAB25-81C2-4476-8D70-44A710A52A4B</gtr:id><gtr:outcomeId>BC92FDC9EB8</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Pontifical Academy of Sciences</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>DB540236-A6AF-424D-BFB8-2188AB064220</gtr:id><gtr:outcomeId>rdSBFjTAFh6</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Science Foundation Ireland, REMEDEI CSET Site Visit</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>C849EA69-93A2-43E0-A39F-AB71792B8F11</gtr:id><gtr:outcomeId>FFC9D5FF76E</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>University of Lund BMC Scientific Advisory Council</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>0FEE30C0-3610-4236-B060-06F66F51122A</gtr:id><gtr:outcomeId>A6C2DE066E3</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Cell Fate and Cancer Programme, Centre for Genomic Regulation, Barcelona, Spain</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>4053086D-980C-4488-B149-155B74881E7D</gtr:id><gtr:outcomeId>56dd79095d0ae5.56112379</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Academy of Medical Sciences Report on Embryo Research and Chimaeras</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>049837C8-275A-4267-BEDD-2B479C1716D4</gtr:id><gtr:outcomeId>9F75D6FFD62</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Riken Advisory Council</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>5736BC3E-B9E9-4F3A-BF97-4057898C0FF7</gtr:id><gtr:outcomeId>5460f26cbd28b4.81452776</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Human na&amp;iuml;ve pluripotent stem cells (2014)</gtr:description><gtr:id>72DC3F8B-A38F-40E6-9709-821D11527E6D</gtr:id><gtr:impact>Patent filed and licensed.</gtr:impact><gtr:outcomeId>58c66d534e90e8.44055943</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human NPSC (2014)</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Human na&amp;iuml;ve epiblast-like stem cells (2016)</gtr:description><gtr:id>27CB49C9-974C-4C0C-B44B-521685B329D0</gtr:id><gtr:impact>Patent filed and licensed.</gtr:impact><gtr:outcomeId>58c66da9185fe1.02178609</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human naive epiblast-like SC</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2A332FBD-DE5F-48FE-9D74-0D331FE069A2</gtr:id><gtr:title>Nanog heterogeneity: tilting at windmills?</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b57ccfaab2cedb549155707885444d88"><gtr:id>b57ccfaab2cedb549155707885444d88</gtr:id><gtr:otherNames>Smith A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>doi_15524_13_06_016_</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>777E7B57-66EC-4FA3-A1A4-6272F0E93BAB</gtr:id><gtr:title>Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1f84914220491618e5899dce349dcb8"><gtr:id>b1f84914220491618e5899dce349dcb8</gtr:id><gtr:otherNames>Moretti A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>5460ffe0e046d4.62034710</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D54E5C5-A9A0-44BE-A61E-D260562494C4</gtr:id><gtr:title>Integrated analysis of single-cell embryo data yields a unified transcriptome signature for the human pre-implantation epiblast.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d54f73719607e4729b5b12f4b8ae7859"><gtr:id>d54f73719607e4729b5b12f4b8ae7859</gtr:id><gtr:otherNames>Stirparo GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>5a6796a687f915.32898762</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97B7411F-EBB5-4FE5-9A1B-76168A400E56</gtr:id><gtr:title>Capture of neuroepithelial-like stem cells from pluripotent stem cells provides a versatile system for in vitro production of human neurons.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63e7d7dc2c1bf5febf2a8cce09e594e5"><gtr:id>63e7d7dc2c1bf5febf2a8cce09e594e5</gtr:id><gtr:otherNames>Falk A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15524_24_22272239</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD906CF5-80DD-46A0-B607-18D7B0235640</gtr:id><gtr:title>Towards consistent generation of pancreatic lineage progenitors from human pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c230ffab60369848ab7c6f4f2ec18316"><gtr:id>c230ffab60369848ab7c6f4f2ec18316</gtr:id><gtr:otherNames>Rostovskaya M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>56dd56cc816e99.91150479</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5ED32AE8-A5B3-4FEB-92C0-5D6C70527AA5</gtr:id><gtr:title>The nature of embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Annual review of cell and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2470b4c214024c6b1a07af2b68d4ef"><gtr:id>9b2470b4c214024c6b1a07af2b68d4ef</gtr:id><gtr:otherNames>Martello G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1081-0706</gtr:issn><gtr:outcomeId>5461029ad62ee0.69480773</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E3C815E-6534-4F60-9C90-519933CA9D76</gtr:id><gtr:title>Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e764902cd8123a2a039be6621814302"><gtr:id>2e764902cd8123a2a039be6621814302</gtr:id><gtr:otherNames>Stricker SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>pm_15524_24_23512659</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27033B40-4967-4E3E-A2F2-BA3C608E49C0</gtr:id><gtr:title>The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5864e17e97d8ca011a04e974d71bfc6"><gtr:id>d5864e17e97d8ca011a04e974d71bfc6</gtr:id><gtr:otherNames>Camnasio S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>pm_15524_24_22405424</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1E42031-AEDC-49F3-A9B0-9221205C2D7F</gtr:id><gtr:title>Human hypoblast formation is not dependent on FGF signalling.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11961079744545ff0447479385de0149"><gtr:id>11961079744545ff0447479385de0149</gtr:id><gtr:otherNames>Roode M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>5461029b7d6cf1.59097613</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BEE53FC-CB10-4905-94FD-9ABD0A83C145</gtr:id><gtr:title>Lineage-Specific Profiling Delineates the Emergence and Progression of Naive Pluripotency in Mammalian Embryogenesis.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14effa92d47d990e142aec1d213deda8"><gtr:id>14effa92d47d990e142aec1d213deda8</gtr:id><gtr:otherNames>Boroviak T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>56dd56cc63f0e9.83035742</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0449BF5F-45DE-4272-999B-D0FD912FC227</gtr:id><gtr:title>Imaging-based chemical screens using normal and glioma-derived neural stem cells.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1719df8f287899239ac12468dc1dea2e"><gtr:id>1719df8f287899239ac12468dc1dea2e</gtr:id><gtr:otherNames>Danovi D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>pm_15524_24_20659005</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F3E5B6B-1107-44A3-9C7A-04B3F44EB722</gtr:id><gtr:title>Stem cells expanded from the human embryonic hindbrain stably retain regional specification and high neurogenic potency.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa3a1a237f1a81f6d5218260735fa337"><gtr:id>fa3a1a237f1a81f6d5218260735fa337</gtr:id><gtr:otherNames>Tailor J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>oVMxmroCoRQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CDED78E-4245-4C61-A480-E3AFC861A82F</gtr:id><gtr:title>A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1719df8f287899239ac12468dc1dea2e"><gtr:id>1719df8f287899239ac12468dc1dea2e</gtr:id><gtr:otherNames>Danovi D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15524_24_24204733</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22C2D27F-EE5E-4B2D-AF34-18B8DF44EFDB</gtr:id><gtr:title>NODAL Secures Pluripotency upon Embryonic Stem Cell Progression from&amp;nbsp;the Ground State.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/159eec0d8d69325f3b8fc93b3ed86d97"><gtr:id>159eec0d8d69325f3b8fc93b3ed86d97</gtr:id><gtr:otherNames>Mulas C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>5a2fd9a5e8d6f8.24071752</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCF6E835-E22F-4EF4-97AE-F61A5F998CF4</gtr:id><gtr:title>Resetting transcription factor control circuitry toward ground-state pluripotency in human.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/085545f0fb93c9e7e7b8b38794c241d5"><gtr:id>085545f0fb93c9e7e7b8b38794c241d5</gtr:id><gtr:otherNames>Takashima Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>5461029b096be5.36362989</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>275A39F8-BB64-4D84-B16D-4F0BC19CF5A7</gtr:id><gtr:title>Epigenetic resetting of human pluripotency.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ce0dd82b76ea1e6106225d40e4fed14"><gtr:id>6ce0dd82b76ea1e6106225d40e4fed14</gtr:id><gtr:otherNames>Guo G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>5a31d6094811d1.25543638</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8682C4FA-7A6B-4C48-92C7-DA94777770F2</gtr:id><gtr:title>Rebuilding pluripotency from primordial germ cells.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/365ad2f4154175d35d30b4af3003cad4"><gtr:id>365ad2f4154175d35d30b4af3003cad4</gtr:id><gtr:otherNames>Leitch HG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>pm_15524_24_24052943</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38883359-7CCC-4A84-B586-7CC295DAC46D</gtr:id><gtr:title>Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a008907b66bd70a4d4e870913498b45"><gtr:id>7a008907b66bd70a4d4e870913498b45</gtr:id><gtr:otherNames>Fujimoto Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_15524_24_22419556</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E65270E5-D4F3-409E-B338-78B8AEF62507</gtr:id><gtr:title>Differentiation of human induced pluripotent stem cells into brown and white adipocytes: role of Pax3.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f127ad22c421c5d6951210f3ebff854"><gtr:id>2f127ad22c421c5d6951210f3ebff854</gtr:id><gtr:otherNames>Mohsen-Kanson T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>546101811ef1b4.32037507</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1001028</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>